Overall | GFR categorya | ||||
---|---|---|---|---|---|
G1 | G2 | G3a | G3b-G5 | ||
MDRD vs. CKD-EPIcrecys | 16.7 (15.9%) | 17.5 (15.1%) | 16.1 (18.3%) | 6.4 (11.1%) | 2.2 (6.0%) |
MDRD vs. CKD-EPIcre | 6.8 (7.1%) | 7.1 (6.6%) | 6.9 (8.4%) | 1.7 (3.1%) | 0.3 (0.8%) |
MDRD vs. CKD-EPIcys | 22.9 (20.6%) | 24.3 (20.4%) | 20.0 (22.2%) | 4.6 (8.2%) | 3.5 (9.1%) |
MDRD vs. LM | 4.7 (5.6%) | 9.6 (9.9%) | 1.5 (1.9%) | 1.4 (2.6%) | 2.6 (7.7%) |
MDRD vs. FAScre | 3.3 (3.6%) | 5.1 (4.7%) | 2.0 (2.5%) | 2.9 (5.5%) | 0.1 (0.1%) |
CKD-EPIcrecys vs. CKD-EPIcre | 9.9 (10.4%) | 10.1 (9.8%) | 9.8 (13.2%) | 5.4 (10.6%) | 1.9 (5.4%) |
CKD-EPIcrecys vs. CKD-EPIcys | 6.2 (5.6%) | 6.6 (5.7%) | 4.3 (5.3%) | 1.1 (2.0%) | 0.8 (2.3%) |
CKD-EPIcrecys vs. LM | 21.4 (25.6%) | 24.0 (26.1%) | 17.6 (24.8%) | 8.3 (16.6%) | 4.8 (14.9%) |
CKD-EPIcrecys vs. FAScre | 13.4 (14.6%) | 12.6 (12.3%) | 16.2 (22.8%) | 9.4 (19.0%) | 2.0 (5.6%) |
CKD-EPIcre vs. CKD-EPIcys | 16.1 (14.5%) | 16.8 (14.2%) | 14.6 (16.8%) | 3.5 (6.2%) | 3.4 (9.0%) |
CKD-EPIcre vs. LM | 11.5 (13.7%) | 15.0 (15.8%) | 8.2 (11.0%) | 3.3 (6.3%) | 2.9 (8.9%) |
CKD-EPIcre vs. FAScre | 3.5 (3.8%) | 2.2 (2.1%) | 5.6 (7.4%) | 4.6 (8.9%) | 0.4 (1.1%) |
CKD-EPIcys vs. LM | 27.6 (33.0%) | 30.1 (33.5%) | 22.1 (32.2%) | 7.0 (13.9%) | 6.1 (18.7%) |
CKD-EPIcys vs. FAScre | 19.7 (21.4%) | 19.4 (19.4%) | 22.3 (32.7%) | 8.0 (16.0%) | 3.0 (8.7%) |
LM vs. FAScre | 8.0 (8.7%) | 13.5 (12.4%) | 3.5 (4.4%) | 1.2 (2.3%) | 2.1 (5.7%) |